| Safety of bacteriophage therapy in severe Staphylococcus aureus infection A Petrovic Fabijan, RCY Lin, J Ho, S Maddocks, NL Ben Zakour, ... Nature microbiology 5 (3), 465-472, 2020 | 324 | 2020 |
| Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii P Knezevic, V Aleksic, N Simin, E Svircev, A Petrovic, N Mimica-Dukic Journal of ethnopharmacology 178, 125-136, 2016 | 226 | 2016 |
| Bacteriophage Therapy of Ventilator-associated Pneumonia and Empyema Caused by Pseudomonas aeruginosa S Maddocks, AP Fabijan, J Ho, RCY Lin, NL Ben Zakour, C Dugan, ... American journal of respiratory and critical care medicine 200 (9), 1179-1181, 2019 | 112 | 2019 |
| Phage therapy for severe bacterial infections: a narrative review AP Fabijan, A Khalid, S Maddocks, J Ho, T Gilbey, I Sandaradura, ... The Medical Journal of Australia 212 (6), 279, 2020 | 54 | 2020 |
| Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus T Gilbey, J Ho, LA Cooley, AP Fabijan, JR Iredell The Medical Journal of Australia 211 (3), 142, 2019 | 49 | 2019 |
| Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child A Khatami, RCY Lin, A Petrovic‐Fabijan, S Alkalay‐Oren, S Almuzam, ... EMBO Molecular Medicine 13 (9), e13936, 2021 | 42 | 2021 |
| Biological foundations of successful bacteriophage therapy C Venturini, A Petrovic Fabijan, A Fajardo Lubian, S Barbirz, J Iredell EMBO Molecular Medicine 14 (7), e12435, 2022 | 35 | 2022 |
| Translating phage therapy into the clinic: recent accomplishments but continuing challenges A Petrovic Fabijan, J Iredell, K Danis-Wlodarczyk, R Kebriaei, ST Abedon Plos Biology 21 (5), e3002119, 2023 | 27 | 2023 |
| Westmead Bacteriophage Therapy Team. 2020 A Petrovic Fabijan, RCY Lin, J Ho, S Maddocks, NL Ben Zakour, ... Safety of bacteriophage therapy in severe Staphylococcus aureus infection …, 2020 | 27 | 2020 |
| Phage biobank: present challenges and future perspectives RCY Lin, JC Sacher, PJ Ceyssens, J Zheng, A Khalid, JR Iredell, ... Current opinion in biotechnology 68, 221-230, 2021 | 26 | 2021 |
| Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation SC Nang, YW Lin, AP Fabijan, RYK Chang, GG Rao, J Iredell, HK Chan, ... Clinical Microbiology and Infection 29 (6), 702-709, 2023 | 19 | 2023 |
| The First Siphoviridae Family Bacteriophages Infecting Bordetella bronchiseptica Isolated from Environment A Petrovic, R Kostanjsek, G Rakhely, P Knezevic Microbial ecology 73, 368-377, 2017 | 18 | 2017 |
| Polyclonal Staphylococcus aureus Bacteremia AP Fabijan, NL Ben Zakour, J Ho, RCY Lin, J Iredell, ... Annals of Internal Medicine 171 (12), 940-941, 2019 | 10 | 2019 |
| Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series H Onallah, R Hazan, R Nir-Paz, MJ Brownstein, JR Fackler, R Hopkins, ... Med 4 (9), 600-611. e4, 2023 | 7 | 2023 |
| L-form switching in Escherichia coli as a common β-lactam resistance mechanism A Petrovic Fabijan, D Martinez-Martin, C Venturini, K Mickiewicz, ... Microbiology Spectrum 10 (5), e02419-22, 2022 | 7 | 2022 |
| Safety and Tolerability of Bacteriophage Therapy in Severe Staphylococcus aureus Infection AP Fabijan, RCY Lin, J Ho, S Maddocks, JR Iredell, ... bioRxiv, 619999, 2019 | 7 | 2019 |
| Do Ganoderma Species Represent Novel Sources of Phenolic Based Antimicrobial Agents? M Rašeta, J Mišković, E Čapelja, E Zapora, A Petrović Fabijan, ... Molecules 28 (7), 3264, 2023 | 6 | 2023 |
| 1642. Safety and efficacy of bacteriophage therapy: analysis of clinical case series data S Aslam, T Gilbey, S Maddocks, S Morales, S Lehman, S Branston, ... Open Forum Infectious Diseases 5 (Suppl 1), S47, 2018 | 5 | 2018 |
| Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child. EMBO Mol Med 2021; 13: e13936 A Khatami, RCY Lin, A Petrovic-Fabijan, S Alkalay-Oren, S Almuzam, ... PUBMED, 0 | 5 | |
| Phages from Genus Bruynoghevirus and Phage Therapy: Pseudomonas Phage Delta Case P Knezevic, A Petrovic Fabijan, D Gavric, J Pejic, Z Doffkay, G Rakhely Viruses 13 (10), 1965, 2021 | 4 | 2021 |
